You have 9 free searches left this month | for more free features.

Tretinoin

Showing 226 - 243 of 243

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Photodamage, Photoaging Trial in Sao Paulo (oral isotretinoin, Tretinoin)

Unknown status
  • Photodamage
  • Photoaging
  • oral isotretinoin
  • Tretinoin
  • Sao Paulo, SP, Brazil
    Federal University of Sao Paulo
Jun 7, 2010

Acne Trial in Mitchellville, Philadelphia (Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel)

Unknown status
  • Acne
  • Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel
  • Mitchellville, Maryland
  • +1 more
May 19, 2010

Acne Vulgaris Trial in Valinhos (application of the topic gel)

Completed
  • Acne Vulgaris
  • application of the topic gel
  • Valinhos, São Paulo, Brazil
    Lal Clinica
May 24, 2010

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Boston (All-trans retinoic acid, Bryostatin 1)

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • All-trans retinoic acid
  • Bryostatin 1
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 9, 2011

Acute Myelogenous Leukaemia (AML), Myelodysplastic Syndrome (MDS) Trial in Paris (5 azacytidine - VALPROIC acid- Retinoic acid)

Completed
  • Acute Myelogenous Leukaemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • 5 azacytidine - VALPROIC acid- Retinoic acid
  • Paris, France
    Chu Saint Louis
May 6, 2011

Lentigo Trial in Santiago (Triple combination cream, Tretinoin 0.05%)

Completed
  • Lentigo
  • Triple combination cream
  • Tretinoin 0.05%
  • Santiago, Chile
    Pontificia Universidad Católica de Chile
Sep 10, 2009

Pigmentation Disorder Trial in Amsterdam (Fraxel Restore, Solta Medical Inc. (Non-ablative fractional laser), Modified Kligman's

Completed
  • Pigmentation Disorder
  • Fraxel Restore, Solta Medical Inc. (Non-ablative fractional laser)
  • Modified Kligman's formula (Triple topical therapy)
  • Amsterdam, Netherlands
    Netherlands Institute for Pigment disorders
Mar 10, 2010

Pigmentation Disorder Trial (Ablative fractional laser therapy)

Completed
  • Pigmentation Disorder
  • Ablative fractional laser therapy
  • (no location specified)
Mar 8, 2010

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Skin Tumors Trial in United States (Tretinoin 0.1% cream or , Placebo)

Completed
  • Carcinoma, Basal Cell
  • +2 more
  • Tretinoin 0.1% cream or placebo
  • Placebo
  • Phoenix, Arizona
  • +6 more
Jan 29, 2009

Rosacea Trial in Conshohocken (tretinoin gel 0.05%, vehicle)

Completed
  • Rosacea
  • Conshohocken, Pennsylvania
    Product Investigations, Inc.
Dec 17, 2008

Healthy Trial in Winston-Salem (Atralin (tretinoin) gel, 0.05%)

Completed
  • Healthy
  • Atralin (tretinoin) gel, 0.05%
  • Winston-Salem, North Carolina
    Suncare Research Laboratories
May 5, 2008

Healthy Trial in Winston-Salem (Atralin (tretinoin) Gel, 0.05%)

Completed
  • Healthy
  • Atralin (tretinoin) Gel, 0.05%
  • Winston-Salem, North Carolina
    Suncare Research Laboratories
Mar 26, 2008

Neuroblastoma Trial in Memphis (Gefitinib, Irinotecan, Cycophosphamide, Doxorubicin, Etoposide, Cisplatin, Topotecan,

Completed
  • Neuroblastoma
  • Gefitinib, Irinotecan, Cycophosphamide, Doxorubicin, Etoposide, Cisplatin, Topotecan, Carboplatin, Melphalan, 13-cis retinoic acid
  • Radiation therapy, Surgery, Peripheral Stem cell transplant
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jun 2, 2008

Breast Cancer, Breast Tumor Trial run by the NCI (9-cis-Retinoic Acid)

Completed
  • Breast Cancer
  • Breast Neoplasm
  • 9-cis-Retinoic Acid
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Mar 3, 2008

Nephroblastoma, Neuroblastoma Trial run by the NCI (IFN-alpha with retinoic acid)

Completed
  • Nephroblastoma
  • Neuroblastoma
  • IFN-alpha with retinoic acid
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Mar 3, 2008

HIV, Immunologic Deficiency Syndromes, Lymphoproliferative Disorders Trial run by the NCI (all-trans-retinoic acid with

Completed
  • HIV Infections
  • +2 more
  • all-trans-retinoic acid with IFN-alpha2a
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Mar 3, 2008

Emphysema, Lung Diseases, Lung Diseases, Obstructive Trial (all trans retinoic acid, 13 cis retinoic acid, )

Completed
  • Emphysema
  • +3 more
  • all trans retinoic acid
  • +2 more
  • (no location specified)
Jan 15, 2008

Leukemia, Promyelocytic, Acute Trial (ATRA, ATRA and or Chemo as maintenance)

Completed
  • Leukemia, Promyelocytic, Acute
  • ATRA
  • ATRA and or Chemo as maintenance
  • (no location specified)
Jan 23, 2008